These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 2141295

  • 21. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA, Pedersen KF, Welsh RM.
    J Immunol; 1986 Jul 15; 137(2):463-71. PubMed ID: 3722814
    [Abstract] [Full Text] [Related]

  • 22. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L, Baenziger J, Pircher H, Hengartner H, Zinkernagel RM.
    J Immunol; 1986 Jun 15; 136(12):4674-80. PubMed ID: 3486908
    [Abstract] [Full Text] [Related]

  • 23. In vivo administration of anti-asialo-GM1 antibody enhances splenic clearance of Listeria monocytogenes.
    Schultheis RJ, Kearns RJ.
    Nat Immun Cell Growth Regul; 1990 Jun 15; 9(6):376-86. PubMed ID: 2128370
    [Abstract] [Full Text] [Related]

  • 24. Antitumor effects of SMANCS on rat mammary tumor induced by 7,12-dimethylbenz[a]anthracene.
    Kimoto A, Konno T, Kawaguchi T, Miyauchi Y, Maeda H.
    Cancer Res; 1992 Feb 15; 52(4):1013-7. PubMed ID: 1531320
    [Abstract] [Full Text] [Related]

  • 25. Characterization of natural killer activity in sponge matrix allografts.
    Hoffman RA, Ascher NL, Jordan ML, Migliori RJ, Simmons RL.
    J Immunol; 1988 Mar 01; 140(5):1702-10. PubMed ID: 3257981
    [Abstract] [Full Text] [Related]

  • 26. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R, Suzuki S, Ebina N, Kumagai K.
    J Immunol; 1985 Apr 01; 134(4):2139-48. PubMed ID: 2579129
    [Abstract] [Full Text] [Related]

  • 27. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
    Masuda E, Maeda H.
    Cancer Res; 1996 Apr 15; 56(8):1868-73. PubMed ID: 8620506
    [Abstract] [Full Text] [Related]

  • 28. [Recent advances in research on SMANCS].
    Maeda H.
    Gan To Kagaku Ryoho; 1998 Feb 15; 25 Suppl 1():1-9. PubMed ID: 9512680
    [Abstract] [Full Text] [Related]

  • 29. In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats.
    Barlozzari T, Reynolds CW, Herberman RB.
    J Immunol; 1983 Aug 15; 131(2):1024-7. PubMed ID: 6863925
    [Abstract] [Full Text] [Related]

  • 30. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
    Hinuma S, Naruo K, Shiho O, Tsukamoto K.
    Immunology; 1986 Oct 15; 59(2):251-9. PubMed ID: 3490435
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of natural killer activity by calcitonin gene-related peptide.
    Umeda Y, Arisawa M.
    Immunopharmacol Immunotoxicol; 1989 Oct 15; 11(2-3):309-20. PubMed ID: 2559931
    [Abstract] [Full Text] [Related]

  • 32. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator.
    Kalland T, Alm G, Stålhandshe T.
    J Immunol; 1985 Jun 15; 134(6):3956-61. PubMed ID: 2580900
    [Abstract] [Full Text] [Related]

  • 33. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A, Nowicky JW.
    Drugs Exp Clin Res; 1996 Jun 15; 22(3-5):103-13. PubMed ID: 8899312
    [Abstract] [Full Text] [Related]

  • 34. Asialo-GM1-positive T killer cells are generated in F1 mice injected with parental spleen cells.
    Knobloch C, Dennert G.
    J Immunol; 1988 Feb 01; 140(3):744-9. PubMed ID: 2448375
    [Abstract] [Full Text] [Related]

  • 35. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL, Chourmouzis E, Sigindere J, MacIntyre JP, Capetola RJ, Lau CY.
    Cell Immunol; 1993 Apr 01; 147(2):302-12. PubMed ID: 8453674
    [Abstract] [Full Text] [Related]

  • 36. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A, Nestel FP, Seemayer TA, Lapp WS.
    J Immunol; 1986 Dec 01; 137(11):3420-7. PubMed ID: 3537120
    [Abstract] [Full Text] [Related]

  • 37. Potentiation of natural killer cell activity and tumor immunity by diacetylputrescine.
    Bowlin TL, Rosenberger A, Stemerick D, Edwards ML.
    Cancer Res; 1990 Sep 01; 50(17):5460-3. PubMed ID: 2386950
    [Abstract] [Full Text] [Related]

  • 38. Antiproliferative effect of YM881 (SMANCS) on glioma cells in vitro.
    Kuratsu J, Takaki S, Kochi M, Mihara Y, Ushio Y.
    Anticancer Res; 1991 Sep 01; 11(6):1957-61. PubMed ID: 1837980
    [Abstract] [Full Text] [Related]

  • 39. Natural cytostatic cells have a broader range of antitumor activity than natural killer cells.
    Kato M, Kawauchi H, Taniguchi K, Katsuki T, Nomoto K.
    J Clin Lab Immunol; 1985 Jan 01; 16(1):47-51. PubMed ID: 3872372
    [Abstract] [Full Text] [Related]

  • 40. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.
    Keller R, Bächi T, Okumura K.
    Exp Cell Biol; 1983 Jan 01; 51(3):158-64. PubMed ID: 6852344
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.